A short review from Dr. Deodhar for axSpA at #RNL2023 *prevalence is increasing *remember the "3,4,5 rule" for MRI eval
Tweet Content
A short review from Dr. Deodhar for axSpA at #RNL2023
*prevalence is increasing
*remember the "3,4,5 rule" for MRI eval
*IL17 appear to be as good as TNFi
*may not need XR monitoring
*time will tell if IL17Fi will improve outcomes
https://t.co/fNhZZBmgaS https://t.co/g0g7e3Napl
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off